purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Study Coverage
1.1 Transdermal and Transmucosal Drug Delivery Revenue in Transdermal and Transmucosal Drug Delivery Business (2017-2022) & (US$ Million) Introduction
1.2 Global Transdermal and Transmucosal Drug Delivery Outlook 2017 VS 2022 VS 2028
1.2.1 Global Transdermal and Transmucosal Drug Delivery Market Size for the Year 2017-2028
1.2.2 Global Transdermal and Transmucosal Drug Delivery Market Size for the Year 2017-2028
1.3 Transdermal and Transmucosal Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Transdermal and Transmucosal Drug Delivery in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Transdermal and Transmucosal Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Transdermal and Transmucosal Drug Delivery Market Dynamics
1.4.1 Transdermal and Transmucosal Drug Delivery Industry Trends
1.4.2 Transdermal and Transmucosal Drug Delivery Market Drivers
1.4.3 Transdermal and Transmucosal Drug Delivery Market Challenges
1.4.4 Transdermal and Transmucosal Drug Delivery Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Transdermal and Transmucosal Drug Delivery by Type
2.1 Transdermal and Transmucosal Drug Delivery Market Segment by Type
2.1.1 Transdermal Drug Delivery
2.1.2 Transmucosal Drug Delivery
2.2 Global Transdermal and Transmucosal Drug Delivery Market Size by Type (2017, 2022 & 2028)
2.3 Global Transdermal and Transmucosal Drug Delivery Market Size by Type (2017-2028)
2.4 United States Transdermal and Transmucosal Drug Delivery Market Size by Type (2017, 2022 & 2028)
2.5 United States Transdermal and Transmucosal Drug Delivery Market Size by Type (2017-2028)
3 Transdermal and Transmucosal Drug Delivery by Application
3.1 Transdermal and Transmucosal Drug Delivery Market Segment by Application
3.1.1 Clinics
3.1.2 Hospitals
3.1.3 Others
3.2 Global Transdermal and Transmucosal Drug Delivery Market Size by Application (2017, 2022 & 2028)
3.3 Global Transdermal and Transmucosal Drug Delivery Market Size by Application (2017-2028)
3.4 United States Transdermal and Transmucosal Drug Delivery Market Size by Application (2017, 2022 & 2028)
3.5 United States Transdermal and Transmucosal Drug Delivery Market Size by Application (2017-2028)
4 Global Transdermal and Transmucosal Drug Delivery Competitor Landscape by Company
4.1 Global Transdermal and Transmucosal Drug Delivery Market Size by Company
4.1.1 Top Global Transdermal and Transmucosal Drug Delivery Companies Ranked by Revenue (2021)
4.1.2 Global Transdermal and Transmucosal Drug Delivery Revenue by Player (2017-2022)
4.2 Global Transdermal and Transmucosal Drug Delivery Concentration Ratio (CR)
4.2.1 Transdermal and Transmucosal Drug Delivery Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Transdermal and Transmucosal Drug Delivery in 2021
4.2.3 Global Transdermal and Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Transdermal and Transmucosal Drug Delivery Headquarters, Revenue in Transdermal and Transmucosal Drug Delivery Business (2017-2022) & (US$ Million) Type
4.3.1 Global Transdermal and Transmucosal Drug Delivery Headquarters and Area Served
4.3.2 Global Transdermal and Transmucosal Drug Delivery Companies Revenue in Transdermal and Transmucosal Drug Delivery Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Transdermal and Transmucosal Drug Delivery Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Transdermal and Transmucosal Drug Delivery Market Size by Company
4.5.1 Top Transdermal and Transmucosal Drug Delivery Players in United States, Ranked by Revenue (2021)
4.5.2 United States Transdermal and Transmucosal Drug Delivery Revenue by Players (2020, 2021 & 2022)
5 Global Transdermal and Transmucosal Drug Delivery Market Size by Region
5.1 Global Transdermal and Transmucosal Drug Delivery Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Transdermal and Transmucosal Drug Delivery Market Size by Region (2017-2028)
5.2.1 Global Transdermal and Transmucosal Drug Delivery Market Size by Region: 2017-2022
5.2.2 Global Transdermal and Transmucosal Drug Delivery Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Transdermal and Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.1.2 North America Transdermal and Transmucosal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Transdermal and Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Transdermal and Transmucosal Drug Delivery Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Transdermal and Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.3.2 Europe Transdermal and Transmucosal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Transdermal and Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.4.2 Latin America Transdermal and Transmucosal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Transdermal and Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Transdermal and Transmucosal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 3M
7.1.1 3M Company Details
7.1.2 3M Business Overview
7.1.3 3M Transdermal and Transmucosal Drug Delivery Introduction
7.1.4 3M Revenue in Transdermal and Transmucosal Drug Delivery Business (2017-2022)
7.1.5 3M Recent Development
7.2 Antares Pharma
7.2.1 Antares Pharma Company Details
7.2.2 Antares Pharma Business Overview
7.2.3 Antares Pharma Transdermal and Transmucosal Drug Delivery Introduction
7.2.4 Antares Pharma Revenue in Transdermal and Transmucosal Drug Delivery Business (2017-2022)
7.2.5 Antares Pharma Recent Development
7.3 Aveva Drug Delivery Systems
7.3.1 Aveva Drug Delivery Systems Company Details
7.3.2 Aveva Drug Delivery Systems Business Overview
7.3.3 Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Introduction
7.3.4 Aveva Drug Delivery Systems Revenue in Transdermal and Transmucosal Drug Delivery Business (2017-2022)
7.3.5 Aveva Drug Delivery Systems Recent Development
7.4 Corium International
7.4.1 Corium International Company Details
7.4.2 Corium International Business Overview
7.4.3 Corium International Transdermal and Transmucosal Drug Delivery Introduction
7.4.4 Corium International Revenue in Transdermal and Transmucosal Drug Delivery Business (2017-2022)
7.4.5 Corium International Recent Development
7.5 DURECT
7.5.1 DURECT Company Details
7.5.2 DURECT Business Overview
7.5.3 DURECT Transdermal and Transmucosal Drug Delivery Introduction
7.5.4 DURECT Revenue in Transdermal and Transmucosal Drug Delivery Business (2017-2022)
7.5.5 DURECT Recent Development
7.6 Pantec Biosolutions
7.6.1 Pantec Biosolutions Company Details
7.6.2 Pantec Biosolutions Business Overview
7.6.3 Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Introduction
7.6.4 Pantec Biosolutions Revenue in Transdermal and Transmucosal Drug Delivery Business (2017-2022)
7.6.5 Pantec Biosolutions Recent Development
7.7 Tapemark
7.7.1 Tapemark Company Details
7.7.2 Tapemark Business Overview
7.7.3 Tapemark Transdermal and Transmucosal Drug Delivery Introduction
7.7.4 Tapemark Revenue in Transdermal and Transmucosal Drug Delivery Business (2017-2022)
7.7.5 Tapemark Recent Development
7.8 Tesa Labtec
7.8.1 Tesa Labtec Company Details
7.8.2 Tesa Labtec Business Overview
7.8.3 Tesa Labtec Transdermal and Transmucosal Drug Delivery Introduction
7.8.4 Tesa Labtec Revenue in Transdermal and Transmucosal Drug Delivery Business (2017-2022)
7.8.5 Tesa Labtec Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer